At a glance
ClinicalIndex Comparison RecordN/ACompleted· 15 enrolled
Drug / intervention
Propel Nova Sinus Implantdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The EXCEED Study: A Clinical Evaluation of the Drug-Eluting Propel Nova Sinus Implant When Placed in Peripheral Sinus Ostia to Maintain Patency
In Brief
A clinical study evaluating Propel Nova Sinus Implant for Chronic Sinusitis. Completed, enrolled 15 participants across 2 sites.
Detailed Summary
This is a feasibility study is to assess the performance, safety and initial signals of efficacy of the drug-eluting Propel Nova Sinus Implant when used in chronic sinusitis patients undergoing sinus surgery of peripheral sinus ostia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Sinusitis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJun 2014
First PostedAug 2014
Primary CompletionOct 2014
Study CompletionJan 2015
TodayJul 2026
First PostedAug 29, 2014
Enrollment StartJun 1, 2014
Primary CompletionOct 1, 2014
Study CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 11.8 years ago
Interventions
Propel Nova Sinus Implantdevice
Bioabsorbable, steroid-releasing sinus implant with 370 mcg of mometasone furoate released over 30 days